Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation

Bone Marrow Transplantation

Volumn 22, Issue 6, 1998, Pages 579-583

  Siegert, W ^a   Beyer, J ^a   Kingreen, D ^a   Blasczyk, R ^a   Baurmann, H ^a   Schwella, N ^a   Schleicher, J ^a   Kirsch, A ^a   Huhn, D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Donor lymphocyte infusion; PBSC; Relapse after BMT

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLAST CELL CRISIS; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LEUKEMIA; LEUKOPENIA; LYMPHOCYTE; MALE; MORTALITY; MULTIPLE MYELOMA; PANCYTOPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE; THROMBOCYTOPENIA;

EID: 0031692165     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701387     Document Type: Article

References (23)

1. Kolb H-J, Mittermüller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
2. Kolb H-J, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
3. Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
4. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.
5. Dermime S, Mavroudis D, Jiang Y-Z et al. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic marrow transplantation. Bone Marrow Transplant 1997; 19: 989-999.
6. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
7. Storb R, Deeg J, Pepe M et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft versus host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729-1734.
8. Tully G, Sullivan KM, Gill P. Analysis of 6 VNTR loci by 'multiplex' PCR and automated fluorescent detection. Hum Genet 1993; 92: 554-562.
9. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
10. Barrett AJ, Locatelli F, Treleaven JG et al. Second transplants for leukemic relapse after bone marrow transplantation: high early mortality but favorable effect of chronic GVHD on continued remission. Br J Haematol 1991; 79: 567-574.
11. Russell LA, Jacobsen N, Heilmenn C et al. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients. Bone Marrow Transplant 1996; 18: 411-414.
12. Bacigalupo A, Soracco M, Vassallo F et al. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 927-932.
13. Hertenstein B, Wiesneth M, Novotny J et al. Interferon alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic marrow transplantation. Transplantation 1993; 56: 1114-1118.
14. Giralt S, Hester J, Huh Y et al. CDS-depleted donor lymphocyte infusion as treatment for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood 1995; 86: 4337-343.
15. van Rhee F, Lin F, Cullis JO et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377-3383.
16. Bär BMAM, Schattenberg A, Mensink EJBM et al. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 1993; 11: 513-519.
17. Drobyski WR, Keever CA, Roth MS et al. Salvage immuno-therapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310-2318.
18. Sica S, Di Mario A, Salutari P et al. Chemotherapy and recombinant human granulocyte colony-stimulating factor primed donor leukocyte infusion for treatment of relapse after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 483-485.
19. Bernasconi P, Alessandrino EP, Caldera D et al. Intensive chemotherapy followed by donor PBSC in ANLL relapsed after allogeneic BMT. Bone Marrow Transplant 1995; 15: 643-645.
20. Trenschel R, Bernier M, Stryckmans P et al. Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 1997; 19: 381-383.
21. Nachbaur D, Duba H-C, Feichtinger H et al. Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML. Bone Marrow Transplant 1997; 19: 947-949.
22. Glass B, Majolino I, Dreger P et al. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 533-541.
23. Flowers MED, Sullivan KM, Martin P et al. G-CSF stimulated donor peripheral blood infusion(s) as immunotherapy in patients with hematologic malignancies relapsing after allogeneic transplantation (abstract). Blood 1995; 86: 564.